623 / 1674
Results
•
14 local relapses (0ne in-quadrant)
•
3 metastatic patients
•
15 deaths
–
3 due BC metastasis
–
7 due to another cancer
–
5 without relation with cancer
•
Median FU: 35,5 months
•
Crude recurrence rate = 2,2%
•
Actuarial recurrence rate after 35,5 months: 1.4%
•
OS at 35.5 months: 98.5%
•
Cancer SS: 98.4%
•
BC SS: 99.5%